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The foundation of sensory pharmacology:
Nicholas (Miklos) Jancso and the Szeged contribution
Gabor Jancso* and Peter Santha
Department of Physiology; University of Szeged; Szeged, Hungary
Capsaicin became an indispensabletool in pain research after the discov-
ery of its unique pharmacological actions
by Nicholas (Miklos) Jancso Jr. in the late
1940s. This “History Article” introduces
his achievements leading to the founda-
tion of “sensory pharmacology” and sub-
sequent research in that field at the
University of Szeged, Hungary.
Motto: “Die Geschichte einer
Wissenschaft ist die Wissenschaft
selbst.” (Goethe)
Capsaicin became an indispensable
tool in pain research after the discovery of
its unique pharmacological actions by
Nicholas (Miklos) Jancso Jr. (Fig. 1) in
the late 1940s. This ”History Article”
introduces his achievements leading to the
foundation of “sensory pharmacology”
and subsequent research in that field at
the University of Szeged, Hungary.
Nicholas (Miklos) Jancso Jr. was born
in Kolozsvar, Hungary (now Cluj-Napoca,
Romania) in 1903 as the only son of
Nicholas (Miklos) Jancso Sr. and Fatime
Paula Halasz. His father was a professor
of internal medicine and a renowned
researcher of malaria at Ferenc Jozsef Uni-
versity in Kolozsvar. He paid special atten-
tion to bringing up his son to be prepared
for a scientific career from his early youth.
After WW1, the family moved to Szeged,
where a new university was inaugurated as
the legal successor of Ferenc Jozsef Uni-
versity in Kolozsvar. Jancso studied at the
Medical Faculty of this university in
Szeged and, after finishing his studies in
1928, took up a position in the Depart-
ment of Pharmacology headed by Bela
Issekutz Sr., who supported Jancso’s career
in many ways. After Professor Issekutz left
for Budapest in 1937, Jancso was
appointed head of the Department of
Pharmacology, a position which he held
until his death in 1966. He was elected a
member of the Hungarian Academy of
Sciences in 1946.
Studies on Chemotherapeutic
Action
Jancso was initially engaged in studies
dealing with problems of the chemothera-
peutic action of trypanocidal compounds.
He spent a 2-year (1929-31) fellowship at
the Robert Koch Institute in Berlin, where
he was very successful in the study of the
mechanisms of action of chemotherapeu-
tic agents. It is beyond the scope of this
short review to cover in full the aspects of
his research in chemotherapy, but it is
worth mentioning that, by using fluores-
cent acridine compounds, he was the first
to demonstrate that systemically injected
chemotherapeutic agents accumulate in
and exert their effects directly on parasites,
as suggested by Paul Ehrlich. Further, he
showed that resistant trypanosomes failed
to accumulate the acridine compounds.
These studies led to the development of a
new class of trypanocidal agents on a
purely theoretical basis, a discovery which
was considered one of the most interesting
discoveries in chemotherapy by J. H. Gad-
dum in his 1954 article “Discoveries in
therapeutics.”
The Phenomenon of Capsaicin
Desensitization
In the course of his experiments on the
mode of action of chemotherapeutic
agents, Jancso became interested in the
role of the reticuloendothelial system
(RES) in the defense mechanisms of the
organism. By developing a technique for
blocking the function of the RES, he stud-
ied the significance of the RES in immu-
nity and chemotherapeutic action. In a
paper published in Nature in 1947,1 he
reported that histamine is the natural acti-
vator of the RES. In that paper, he also
showed that histamine activates endothe-
lial cells, resulting in an increased vascular
permeability, which could be visualized
through the phenomenon of angiopexis or
vascular labeling. As he put it, by using
histamine it is possible to “write” onto the
skin of animals injected with colloidal car-
bon (Indian ink). In histological prepara-
tions, many carbon-labeled small blood
vessels (mainly postcapillary venules)
could be visualized following painting of
the skin with histamine after the prior
intravenous injection of Indian ink. This
histamine-induced inflammatory reaction,
i.e., vascular labeling, could be prevented
by repeated painting of the skin with
solutions of histamine of increasing
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concentrations, a procedure termed local
histamine desensitization.
Jancso noted that, besides histamine,
many chemical irritants can elicit the phe-
nomenon of vascular labeling by producing
cutaneous inflammation. Among the irri-
tants, capsaicin, the pungent agent in red
peppers (paprika) and mustard oil (allyl
isothiocyanate), also produced vascular
labeling. Since histamine desensitization
prevented the development of this reaction,
Jancso at first believed that the responses eli-
cited by irritants may also be mediated
through the release of histamine. The next
step, i.e., to prevent the capsaicin-induced
inflammatory response by repeated local
applications of the irritant, appeared obvi-
ous, at least in retrospect. The experiments
showed that the capsaicin-induced inflam-
matory response could be largely inhibited
by prior repeated administrations of the
drug, a procedure termed capsaicin desensi-
tization. Some authors who commented on
these observations suggested that this dis-
covery might be seen as a typical case of ser-
endipity. In our opinion, this interpretation
is mistaken, since, as described above, this
discovery was a result of a series of well-
thought out experiments where observa-
tions and experience obtained in previous
experiments on the actions of histamine
were consciously applied to resolve a new
scientific issue. N. Jancso’s own comments
on these experiments in his monograph
“Speicherung”2 support this conclusion:
“Unser Befund, dass die scharfschmecken-
den Verbindungen die kleinen ven€osen
Gef€asse ebenso aktivieren wie das Histamin,
erweckte den Gedanken, dass €ahnliche
Gew€ohnungserscheinungen auch bei dieser
Stoffgruppe vorkommen k€onnten. Der
Einfall erwies sich als fruchtbar: es ist uns
tats€achlich gelungen, das interessante
Ph€anomen der Capsaicindesensibilisierung
zu entdecken.” (“Our finding that pungent
compounds activate small venules like
histamine, raised the idea that analogous
adaptation phenomena may also occur in
the case of these agents. This idea proved
fruitful: in fact, we succeeded in discover-
ing the interesting phenomenon of capsa-
icin desensitization.”) These experiments
laid the foundations of future research
conducted with ingenious insight into the
pharmacological effects of capsaicin, lead-
ing to the establishment of new fields in
pharmacology and neuroscience, sensory
pharmacology and the neurobiology of
nociceptors.
It is worthy of mention that studies on
the pharmacological effects of capsaicin
on sensory functions were initiated at Fer-
enc Jozsef University in Kolozsvar (now
the “Iuliu Hatieganu” University of Medi-
cine and Pharmacy, Cluj-Napoca, Roma-
nia [it is interesting to note that I.
Hatieganu was a pupil and assistant of N.
Jancso Sr.]) and its legal successor, Ferenc
Jozsef University in Szeged (after 1945 the
University Medical School, and after
1990 the University of Szeged). The first
observations on the actions of capsaicin
were made by Endre Ho gyes in Kolozsvar
in the 1870s. His most important sugges-
tion was that capsaicin exerts its effect
through its action on sensory nerves. In
the 1920s, the renowned chemist T. Szeky
undertook systematic studies on the rela-
tion of pungency and chemical structure.
Several compounds synthesized by Szeky
were later used by Jancso for structure-
activity studies of the irritancy and desen-
sitizing properties of capsaicin congeners.
Activation and Desensitization
of Pain Receptors by Capsaicin
The first results on the unique effects of
capsaicin were communicated by N.
Jancso (Fig. 2) and his wife Aurelia
Jancso-Gabor at the annual meeting of the
Hungarian Physiological Society in Buda-
pest in 1949. It is relevant to cite a section
of the abstract of this contribution here
because it gives a brief, succint summary
of the salient actions of capsaicin on noci-
ceptive primary sensory neurons (trans-
lated from the Hungarian by one of the
authors [G. J.] of this article).
“Certain agents affect sensory nerve
endings in a hitherto unknown way, as
they are capable of the desensitization of
sensory nerve endings to chemical stimuli
without causing true local anesthesia. It is
characteristic of the desensitization of
sensory nerve endings that, while reflexes
elicited by their physical (mechanical)
stimulation can be promptly elicited,
the desensitized area is mostly or
completely insensitive toward the stimu-
lating effects of certain chemical agents.
Such a desensitizing agent is capsaicin, the
effect of which lasts for days and is chemi-
cally non-specific. If a solution of capsai-
cin is instilled repeatedly into the eyes of
rats or guinea pigs, it will desensitize the
eye and, finally, the animals fail to experi-
ence the irritant effect of this agent. The
eyes treated in this way have also become
insensitive to other types of strong irri-
tants and lachrymose agents: the sensitiv-
ity of the eye may decrease as much as
1000-fold. Using repeated treatments, we
succeeded in desensitizating the sensory
nerve endings of the skin and the airways
too.”
Subsequent studies disclosed that the
systemic administration of capsaicin to
rats, mice, guinea pigs and dogs produces
a long-lasting insensitivity to capsaicin and
other pain-producing irritants with diverse
chemical structures. The sensitivity to non-
noxious and noxious mechanical stimuli
was preserved. These findings describing
the unique desensitization of nociceptive
afferents by capsaicin were communicated
only as a short abstract by N. Jancso and
A. Jancso-Gabor in 1959.3 Electrophysio-
logical studies conducted by J. Porszasz
and N. Jancso supported a selective effect
of capsaicin on sensory C-fibers and
pointed to a peripheral site of action of
the drug.4 The term “sensory neuron
blocking agent” was coined by Jancso to
denote the selective effect of capsaicin on
nociceptive primary afferent neurons.
Studies on the Mechanisms
of Neurogenic Inﬂammation
Detailed studies on the mechanism of
inflammatory reactions, such as the vasodi-
latation and plasma protein extravasation
evoked by capsaicin and some other irri-
tants, including mustard oil and xylene,
revealed that they are produced through
the activation of sensory nerve endings.
Desensitization with capsaicin abolished
these vascular reactions collectively termed
the neurogenic inflammatory response.
Similarly, capsaicin or mustard oil-induced
plasma extravasation was completely abol-
ished by chronic sensory denervation.
Jancso hypothesized that these vascular
phenomena are of neurogenic origin and
are mediated by a “neurohumour” released
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from sensory nerve endings which are sen-
sitive to capsaicin. He also suggested that
these chemosensitive nerve endings possess
a dual function: they transmit nociceptive
information toward the central nervous
system, and they also release a neurohu-
mour from their peripheral endings, which
produces local vasodilatation and an
increase in vascular permeability, i.e. neu-
rogenic inflammation. This concept dif-
fered significantly from the classical axon
reflex theory of Lewis, although neurogenic
inflammation and especially neurogenic
sensory vasodilatation are related phenom-
ena. Whereas the axon reflex theory
hypothesized separate axon collaterals with
afferent and efferent functions, respectively,
Jancso suggested that the sensory axon col-
laterals are similar and, if stimulated,
propagate action potentials conveying
nociceptive information toward the central
nervous system and concomitantly release
vasoactive mediators which produce the
neurogenic inflammatory response in the
periphery. He also showed that local anes-
thetics inhibited the transmission of noci-
ceptive information, but failed to affect the
neurogenic inflammation. Extensive study
of the functions of these particular chemo-
sensitive afferent nerves sensitive to capsai-
cin revealed that they are involved in a
variety of functions of many organs and
tissues of the body, now generally referred
to as the sensory efferent or local regula-
tory function of sensory nerves (for a
review and references, see ref. 5).
Acording to N. Jancso, the depletion of
the “neurohumour,” later identified as
neuropeptides such as substance P and cal-
citonin gene-related peptide contained in
primary afferent neurons, may explain the
characteristic features of desensitization
following the administration of large doses
of capsaicin. Although the mechanisms of
capsaicin desensitization turned out to be
more complex, and still not clarified in all
details, this contention is still valid as far
as the sensory efferent/local regulatory
functions of nociceptors are considered.
Effects of Capsaicin on
Thermoregulation
The first report on the thermoregula-
tory effects of capsaicin and related
compounds was published by N. Jancso in
“Speicherung.”2 This monograph gave a
thorough account of the extensive research
which he had pursued over a period of
about 20 years on the functions of tissue
macrophages, the RES and the storage
function of kidney tubular cells. Several
chapters dealt with issues concerning the
mechanisms of neurogenic inflammation
elicited with capsaicin and other irritants.
He studied the effects of a number of
related compounds in order to determine
the structural requirements for com-
pounds to meet to be able to activate the
pain receptors. It was established that the
presence of a substituted aromatic ring
and the acylamide bond is essential for the
induction of activation and the subse-
quent desensitization of pain receptors.
In the course of the study of the mecha-
nism of capsaicin desensitization, the effects
of capsaicin on thermoregulation were also
revealed. Animals given single low systemic
doses of capsaicin developed a marked, but
transient decrease in body temperature of
up to 5–7C. Interestingly, animals given
large systemic doses of capsaicin developed
a long-lasting, apparently irreversible
impairment of the regulation of their body
temperature in a warm environment. Cap-
saicin-desensitized rats also exhibited an
exaggerated febrile response to pyrogens.
Although the exact mechanism of this ther-
moregulatory disturbance is still unclear,
besides an altered function of peripheral
warm sensors, an impairment of hypotha-
lamic “thermodetectors” was demonstrated.
Experiments by N. Jancso, J. Szolcsanyi
and K. Thuranszky disclosed that the injec-
tion of capsaicin into the hypothalamic
preoptic area produced decreases in core
body temperature in cats and rats. Further,
repeated injections of capsaicin produced
desensitization to its own effect and abol-
ished the thermoregulatory responses of
hypothalamic warming too. In the 1980s,
the thermoregulatory effects of capsaicin
and the relationship between thermoregula-
tion and sleep were further studied by Fer-
enc Obal, Jr. and his colleagues. Inter
alia, they observed that central impairments
in thermoregulation were much less
pronounced in rats treated neonatally with
capsaicin; hence, centrally administered
capsaicin, serotonin and hypothalamic
warming elicited thermoregulatory
responses similar to those in the controls.
These findings were of particular impor-
tance in the light of recent findings that
antagonists of the capsaicin/transient recep-
tor potential vanilloid type 1 (TRPV1)
receptor, regarded as potential analgesics,
produced hyperthermia in both animals
and man.
The Legacy of Nicholas Jancso
The engagement of N. Jancso in the
study of pain mechanism by using capsai-
cin and related compounds as research
tools spanned over more then 2 decades
from the early 1940s until his untimely
death at the age of 63 in 1966. During his
lifetime, almost nothing of these funda-
mental findings was published in interna-
tional scientific journals for various
reasons. Publication from an Eastern
European country in western scientific
journals was not easy for political reasons
and additionally he had become tired of
arguing with journal referees. In the early
days of “capsaicin research,” the attitude
toward the new ideas of N. Jancso on the
pharmacology of pain receptors can be
well illustrated by quoting Lembeck’s
comment6 on a lecture given by N. Jancso
in T€ubingen: “I knew Jancso’s work on
the extinction of pain by capsaicin. I
invited him to T€ubingen for a seminar.
Jancso explained in the seminar his sim-
ple, but conclusive experiments, and I was
probably the only one in the audience
who was convinced that he was right.”
This was not a unique experience in the
course of “capsaicin research.” Much later,
in 1987, one of the present authors (G. J.)
received harsh criticism from reviewers of
a highly rated scientific journal of the field
in connection with a manuscript discus-
sing the possible use of capsaicin-type
compounds for pain relief. Nowadays,
however, the use of capsaicin and related
agents, including the capsaicin receptor
antagonists, in pain therapy is common-
place and further possibilities for their use
to alleviate pain are continuously sought
for.
Most of the results of N. Jancso’s experi-
ments on the effects of capsaicin were pub-
lished in detail only after his death, by his
wife, Aurelia [Aranka] Jancso-Gabor, who
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had been working with him from the very
beginning of the studies concerned with the
pharmacological actions of capsaicin, and
by Janos Szolcsanyi, who joined Jancso only
4 years before Jancso’s death in 1966. N.
Jancso and A. Jancso-Gabor reported on
the first results of the highly selective desen-
sitizing effect of capsaicin at the XVth
Meeting of the Hungarian Physiological
Society in 1949, and at a meeting of the
German Pharmacological Society in 1959,
and on the thermoregulatory effects of cap-
saicin in 1965 at a meeting of the German
Pharmacological Society. Together with A.
Jancso-Gabor, Szolcsanyi made a valuable
contribution by summarizing and publish-
ing the most important data and concepts
of Jancso’s work in the next few years before
leaving Szeged.
N. Jancso’s groundbreaking observa-
tions not only demonstrated the possibil-
ity that the function of nociceptive
primary sensory neurons can be funda-
mentally influenced by pharmacological
means, but also clarified many aspects of
the function of pain receptors, apart from
their role in the sensation of pain. His
achievements were honored by several
national and international awards and by
comments from great Hungarian scien-
tists, including Janos (John) Szentagothai,
who remembered him in his introductory
remarks to a symposium on “Capsaicin
and the sensory system” held in Budapest
in 1985, as follows: “Jancso was undoubt-
edly the greatest genius of post World
War II Hungarian biomedical sciences.”
The Discovery of the Selective
Neurotoxic Effect of Capsaicin
and its Signiﬁcance
Although N. Jancso’s results had
clearly revealed that capsaicin acts in a
very specific, unique way on pain recep-
tors, the morphological identity, the neu-
rochemical profile and the possibilities to
block the function of nociceptive afferents
serving specific tissues or organs remained
to be clarified. The discovery of the selec-
tive neurotoxic/neurodegenerative action
of capsaicin contributed significantly to
the tackling of these important issues. In
1977, one of the present authors (G. J.)
and his colleagues, Elizabeth Kiraly and A.
Jancso-Gabor, published a paper in
Nature7 demonstrating that capsaicin
administered to newborn rats resulted in
the selective degeneration and life-long
elimination of C-fiber chemosensitive pri-
mary sensory neurons, amounting to
about 50% of the total neuronal popula-
tion in the spinal and cranial sensory gan-
glia. The effect of this sensory neurotoxin
was specific for nociceptive primary affer-
ent neurons which transmit chemogenic
pain and mediate the neurogenic inflam-
matory response. By making use of the
selective neurotoxic effect of capsaicin the
central nervous system distribution of spi-
nal and cranial nociceptive primary affer-
ents was revealed for the first time
through the use of classical light and elec-
tron microscopic histological techniques.
Since neonatal capsaicin treatment produ-
ces selective chemodenervation by elimi-
nating nociceptive primary sensory
neurons, comparative immunohistochem-
ical studies on control and capsaicin-
treated animals provided an opportunity
for the identification of the putative pep-
tide mediator(s) of pain. This was made
possible through collaboration with Pro-
fessor Tomas H€okfelt and his colleagues
at the Karolinska Institutet, with whom
Ferenc Joo, my (J. G.) first mentor, and
Norbert Halasz, who at that time was
working at the Karolinska Institutet,
maintained good personal relationships.
These studies supported and extended
previous findings by showing that, besides
substance P, other peptides, such as
somatostatin and cholecystokinin, are also
present in nociceptive spinal and cranial
sensory ganglion cells. The putative trans-
mitter role of substance P in capsaicin-sen-
sitive primary afferents was suggested in
1978 by Jessel, based, in part, on our ear-
lier findings that capsaicin treatment
resulted in the abolition of fluoride-resis-
tant acid phosphatase from the substantia
gelatinosa, the principal termination site
of nociceptive afferents: “The striking sim-
ilarity between the distribution of sub-
stance P and the fluoride-resistant acid
phosphatase in spinal cord led us to inves-
tigate the possibility that capsaicin-
induced desensitization may be mediated
by an action on substance P-containing
primary afferent terminals in the substan-
tia gelatinosa.”
Figure 1. Nicholas Jancso in the late 1950s. This photograph was taken in the Department of Phar-
macology, University of Szeged. (From the family archive of G. Jancso).
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The experimental paradigm involving
comparative studies on control and neona-
tally capsaicin-treated animals which
lacked C-fiber nociceptive primary affer-
ent neurons was extensively utilized in
many laboratories to study the contribu-
tion of this special population of afferents
to mechanisms of pain, inflammation,
immune responses and a variety of visceral
functions. In our laboratory, experiments
in this respect revealed the role of chemo-
sensitive afferent nerves in the modulation
of cutaneous inflammatory reactions, the
cardiac function and protection, cardiore-
spiratory reflexes, headache mechanisms,
gastrointestinal circulation and thermo-
regulation (for reference see Nagy et al.8).
The observations on the neurotoxic
effects of capsaicin facilitated further
research in many ways. According to Gold
and Caterina,9 “One early clue that noci-
ceptive neurons might express signaling
proteins distinct from those of other neu-
ronal subtypes was the observation that
exposure of neonatal rats to capsaicin, the
main pungent ingredient in hot peppers,
produces a lifelong depletion of small-
diameter sensory neurons, with no such
effects on larger diameter neurons. As
adults, these animals exhibit diminished
responsiveness not only to subsequent
capsaicin challenge, but also to other pain-
ful stimuli (Jancso, G. et al., 1977).” The
observation that the administration of
capsaicin elicited an increase in intracellu-
lar free calcium concentration was later
utilized for the selection of clones of cul-
tured sensory ganglion cells which
expressed the capsaicin/vanilloid receptor
type 1. Evidence for the existence of a cap-
saicin receptor was presented in 1990 by
Szallasi and Blumberg in binding studies
involving the use of resiniferatoxin. The
cloning and identification by Caterina and
his colleagues9 of the capsaicin receptor,
in 1997, as a non-selective cation channel
with a high calcium permeability, now
termed the TRPV1 receptor, was of fun-
damental significance as regards further
investigations into the molecular mecha-
nisms of nociception and the evaluation
of the role of TRPV1 receptors in a variety
of somatic and visceral functions, and in
the central nervous system.
Obviously, neonatal treatment with
capsaicin affects all capsaicin-sensitive
primary afferent neurons in the organism.
In further experiments, however, we made
the observation that local application of
capsaicin onto a peripheral nerve selec-
tively and permanently blocked the func-
tion of nociceptive afferents. Hence, by
using this approach, it is possible to pro-
duce a selective chemodenervation of any
tissue or organ by treating the nerves
which serve them with capsaicin. This
technique has therefore become a widely
used approach with which to study the
functional significance of these particular
somatic and visceral, e.g., vagal nocicep-
tive afferents in different physiological or
pathological processes. Since this treat-
ment produces selective regional analgesia,
it has been proposed as a possible
approach to alleviate pain. The findings
additionally pointed to the possibility that
axons of nociceptive neurons also express
receptors sensitive to capsaicin. One of the
authors of this article (G. J.) had the
privilege to clarify the neurochemical con-
sequences of perineural capsaicin treat-
ment with Rainer Gamse and Ulrike
Petsche in the laboratory of Professor Fred
Lembeck, who was impressed by the idea
of blocking the function of nociceptive
afferents in that way (“again such a simple
clever Hungarian idea”). It emerged that
perineural capsaicin selectively blocks axo-
nal transport processes in sensory nerves
and results in the long-lasting depletion of
neuropeptides from sensory ganglion cells.
Other modes of application of capsai-
cin, such as injection of the drug into the
subarachnoid space, have also been intro-
duced, thereby contributing further to the
understanding of the functional traits of
chemosensitive primary afferent neurons.
Hence, the observations that, following an
intracisternal injection of capsaicin, the
protective wiping reflex observed in con-
trols after the instillation of zingerone or
capsaicin into the eye of the rat was
Figure 2. N. Jancso and A. Jancso-Gabor in the late 1950s. The note on the back of the photograph
indicates that the 2 guinea-pigs have already been desensitized with capsaicin and are no longer
sensitive to chemical irritants. This photograph was taken in the Department of Pharmacology, Uni-
versity of Szeged. (From the family archive of G. Jancso).
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completely abolished, but the ability of
irritants such as capsaicin or mustard oil
to produce neurogenic inflammation in
the eyelids or in the skin remained unaf-
fected, provided direct experimental evi-
dence of the dual functional character of
these nociceptive primary afferent neu-
rons. Morphological and neurochemical
studies revealed that, under these experi-
mental conditions, dissociation of the
afferent and the efferent functions of noci-
ceptive neurons could be accounted for by
a selective degeneration of the central
medullary terminations of these neurons.
It was suggested that the sensory ganglion
cell perikaryon with its peripheral pro-
cesses comprises an independent func-
tional entity capable of responding to
peripheral (inflammatory) stimuli by the
release of vasoactive peptides from its
peripheral endings, independently of the
central nervous system, i.e., without the
contribution of a dorsal root root reflex,
for instance.
Novel Mechanisms Involved in
Nociceptor Analgesia
Studies on the chemical changes of
injured primary sensory neurons led us to
examine the possible role of gangliosides,
and in particular GM1, in the nociceptor
function. Experiments on cultured dorsal
root ganglion cells revealed that the inhi-
bition of neural ganglioside synthesis sig-
nificantly reduced not only the activation
of the TRPV1 ion channel by capsaicin in
DRG neurons, but also the expression of
the TRPV1 receptor protein. We sug-
gested that pharmacological manipulation
of the intracellular level of certain ganglio-
side species may provide a novel approach
for modulation of the nociceptor function
and possibly for the production of noci-
ceptor analgesia.10
Final Remarks
The ultimate goal of research in the
field of pain is undoubtedly the develop-
ment of novel analgesics and better treat-
ment options. Although our knowledge
on pain mechanisms has been greatly
advanced through the introduction of cap-
saicin into the study of sensory functions,
the possibility of translating theoretical
knowledge into treatment options remains
a continuing challenge for pain medicine.
It is the authors’ hope that readers of
this “History Article” may find it interest-
ing to catch a glimpse of the beginnings
and early developments in a research field
that has now firmly established itself
in the realm of modern neuroscience.
A critical evaluation of the work of N.
Jancso and other researchers in Szeged
possibly awaits further “History Articles.”
However, it is probably appropriate to
state that their concepts, methods and
experimental approaches to the study of
the problems of pain may have left a last-
ing impact on research in sensory
physiology.
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